ASML reports €27.6 billion net sales and €7.8 billion net income in 2023

                   2024 expected to be a transition year with sales similar to 2023




                                              ASML 2023 Fourth-Quarter and Full-Year results
                                                                 Veldhoven, the Netherlands

                                                                           January 24, 2024
                                                                                               Public
Agenda

• Investor key messages
• Business summary
• Outlook
• Financial statements




    January 24, 2024       Page 2
                          Public
          Investor key messages




January 24, 2024                   Page 3
                                  Public
Investor key messages
 •    Global megatrends in the electronics industry, supported by a highly profitable and fiercely
      innovative ecosystem, are expected to continue to fuel growth across the semiconductor market
 •    Growth in semiconductor end markets and increasing lithography intensity are driving demand for
      our products and services
 •    ASML’s comprehensive product portfolio is aligned with our customers’ roadmaps, delivering cost
      effective solutions in support of all applications from leading edge to mature nodes
 •    Based on different market scenarios1 as presented during our Investor Day in November 2022, we
      modeled an opportunity to reach annual revenue in 2025 between approximately €30 billion and
      €40 billion, with a gross margin between approximately 54% and 56% and in 2030 an annual
      revenue between approximately €44 billion and €60 billion, with a gross margin between
      approximately 56% and 60%
 •    ASML and its supply chain partners are actively adding and improving capacity to meet current and
      future customer demand
 •    We continue to execute our ESG Sustainability strategy and will share the latest progress and
      actions to reach our targets in our integrated Annual Report 2023, to be published on February 14,
      2024
 •    We expect to continue to return significant amounts of cash to our shareholders through a
      combination of growing dividends and share buybacks
     January 24, 2024   1 based on third party research and our assumptions                                 Page 4
                                                                                                           Public
          Business summary




January 24, 2024              Page 5
                             Public
2023 - Business summary
 ASML achieved a sales growth of 30%, reflecting the continued strong global demand for our products:
  • Net sales grew to €27.6 billion at 51.3% gross margin
  • Net income at €7.8 billion resulted in an EPS of €19.91

EUV lithography:
  • EUV system sales grew 30% to €9.1 billion, recognized revenue on 53 systems and shipped 42 systems
  • Shipped the first modules of the first High NA EUV EXE:5000 system

DUV lithography:
  • DUV system sales grew 60% to €12.3 billion, recognized revenue on 396 systems of which 32% immersion systems
  • Shipped the first NXT:1980Fi immersion systems as well as the XT:400M i-line systems

Applications:
  • Our Metrology & Inspection systems sales declined 19% to €536 million due to lower YieldStar systems sales
  • Shipped the first YieldStar 500 systems

Installed Base1:
  • Our Installed Base business declined 2% to €5.6 billion due to lower upgrade business

Capital return:
  • Returned €3.3 billion to shareholders through dividends and share buybacks

     January 24, 2024   1 Installed Base Management equals our net service and field option sales                   Page 6
                                                                                                                   Public
Shipped 1st modules of 1st High NA EUV EXE:5000 system
Increased NA enables cost effective shrink with increased transistor density




      January 24, 2024                                                          Page 7
                                                                               Public
Q4 results summary

  • Net sales of €7.2 billion, net system sales of €5.7 billion, Installed Base
    Management1 sales of €1.6 billion
  • Gross margin of 51.4%
  • Operating margin2 of 33.1%
  • Net income as a percentage of net sales of 28.3%
  • Earnings per share (basic) of €5.21
  • Net bookings3 of €9.2 billion
           ◦ including EUV bookings of €5.6 billion

  1 Installed Base Management equals our net service and field option sales

  2 Income from operations as a percentage of Total net sales

  3 Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.


    January 24, 2024                                                                                                                        Page 8
                                                                       Numbers have been rounded for readers' convenience.                 Public
  Net system sales breakdown (Quarterly)


    Q4’23
Net system sales
€5,683 million




    Q3’23
Net system sales
€5,308 million




          January 24, 2024                  Page 9
                                           Public
  Net system sales breakdown (Yearly)


     2023
Net system sales
€21,939 million




     2022
Net system sales
€15,430 million




          January 24, 2024              Page 10
                                        Public
Total net sales € million by End-use



                                                                            Installed Base
                                                                            Management1

                                                                            Logic

                                                                            Memory




1 Installed Base Management equals our net service and field option sales



           January 24, 2024                                                                  Page 11
                                                                                             Public
Net systems bookings1 activity by End-use


                          Q4’23 net system bookings
                               €9,186 million




                          Q3’23 net system bookings
                               €2,602 million




1 Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.



           January 24, 2024                                                                                                              Page 12
                                                                                                                                         Public
  Capital return to shareholders
                 • ASML intends to declare a total dividend for the year 2023 of €6.10 per ordinary share. An
                   interim dividend of €1.45 per ordinary share will be made payable on February 14, 2024

                 • Recognizing this (third) interim dividend and the two interim dividends of €1.45 per ordinary
                   share paid in 2023, this leads to a final dividend proposal to the General Meeting of €1.75 per
                   ordinary share

                 • In Q4 2023 no shares were purchased



Total dividend

Interim dividend                                                                                                Dividend paid
(paid)
                                                                                                                Share buyback
Interim dividend
(to be paid)
Proposed final
dividend



                         Third interim and final dividend for a year are paid in the subsequent year
              January 24, 2024                                                                                             Page 13
                                                                                                                          Public
          Outlook




January 24, 2024    Page 14
                    Public
Outlook
   Q1
        •             Net sales between €5.0 billion and €5.5 billion, including
                      ◦         Installed Base Management1 sales of around €1.3 billion
        •             Gross margin between 48% and 49%
        •             R&D costs of around €1,070 million
        •             SG&A costs of around €300 million


   2024
        •             Similar net sales with a slightly lower gross margin, relative to 2023
        •             Estimated annualized effective tax rate between 16% and 17%




   January 24, 2024       1 Installed Base Management equals our net service and field option sales   Page 15
                                                                                                      Public
          Financial Statements




January 24, 2024                 Page 16
                                 Public
Consolidated statements of operations € million
Year on Year
                                                                                           2019               2020                2021                2022                2023
                                                         Net sales                       11,820             13,979              18,611              21,173              27,559
                                                      Gross profit                        5,280              6,798               9,809              10,700              14,136
                                                  Gross margin %                           44.7               48.6                52.7                50.5                51.3
                                                   Other income 1                            —                  —                  214                  —                   —
                                                       R&D costs                         (1,968)            (2,201)             (2,547)             (3,254)             (3,981)
                                                      SG&A costs                           (521)              (545)               (726)               (946)             (1,113)
                                           Income from operations                         2,791              4,051               6,750               6,501               9,042
                              Operating income as a % of net sales                         23.6               29.0                36.3                30.7                32.8
                                                       Net income                         2,592              3,554               5,883               5,624               7,839
                                   Net income as a % of net sales                          21.9               25.4                31.6                26.6                28.4
                                      Earnings per share (basic) €                         6.16               8.49               14.36               14.14               19.91
                                     Earnings per share (diluted) €                        6.15               8.48               14.34               14.13               19.89
                                Lithography systems sold (units) 2                          229                258                 309                 345                 449
                                                   Net bookings 3                        11,740             11,292              26,240              30,674              20,040
1   Other income includes the gain on the sale of Berliner Glas subsidiaries
2   Lithography systems do not include metrology and inspection systems
3   The sum of quarterly net bookings over the full year. Our 2019 systems net bookings include 1 EUV and 1 DUV order shipped to our collaborative Research Center (Imec). These
    systems were not recognized in revenue.



           January 24, 2024                                                                                                                                                                  Page 17
                                                                          These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.   Public
Consolidated statements of operations € million
Quarter on Quarter
                                                                                         Q4 2022             Q1 2023             Q2 2023             Q3 2023            Q4 2023
                                                         Net sales                         6,430               6,746               6,902               6,673              7,237
                                                      Gross profit                         3,311               3,413               3,544               3,462              3,717
                                                  Gross margin %                            51.5                50.6                51.3                51.9               51.4
                                                       R&D costs                            (906)               (948)             (1,000)               (992)            (1,041)
                                                      SG&A costs                            (280)               (260)               (281)               (288)              (284)
                                           Income from operations                          2,125               2,205               2,263               2,182              2,392
                              Operating income as a % of net sales                          33.0                32.7                32.8                32.7               33.1
                                                       Net income                          1,817               1,956               1,942               1,893              2,048
                                   Net income as a % of net sales                           28.2                29.0                28.1                28.4               28.3
                                      Earnings per share (basic) €                          4.60                4.96                4.93                4.81               5.21
                                     Earnings per share (diluted) €                         4.60                4.95                4.93                4.81               5.20
                                Lithography systems sold (units) 1                           106                 100                 113                 112                124
                                                   Net bookings 2                          6,316               3,752               4,500               2,602              9,186


1   Lithography systems do not include metrology and inspection systems.
2   Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.



           January 24, 2024                                                                                                                                                                      Page 18
                                                                              These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.   Public
Consolidated statements of cash flows € million
Year on Year
                                                                                                        2019              2020             2021             2022              2023
                              Cash and cash equivalents, beginning of period                           3,121             3,532            6,049            6,952             7,268

                          Net cash provided by (used in) operating activities                          3,276             4,628          10,847             8,487             5,443
                           Net cash provided by (used in) investing activities                        (1,158)           (1,352)            (72)           (1,029)           (2,689)
                           Net cash provided by (used in) financing activities                        (1,712)             (753)         (9,892)           (7,138)           (3,003)
                                Effect of changes in exchange rates on cash                                5                (5)             20                (4)              (14)
                       Net increase (decrease) in cash and cash equivalents                              411             2,517             903               316              (263)

                                 Cash and cash equivalents, end of period                              3,532             6,049            6,952            7,268             7,005
                                                  Short-term investments                               1,186             1,302              638              108                 5
                     Cash and cash equivalents and short-term investments                              4,718             7,351            7,590            7,376             7,010

      Purchases of property, plant and equipment and intangible assets                                  (885)           (1,001)            (940)          (1,319)           (2,196)
                                                      Free cash flow 1                                 2,391             3,627            9,906            7,168             3,247


1   Free cash flow, which is a non-GAAP measure, is defined as net cash provided by (used in) operating activities minus purchases of Property, plant and equipment and
    intangible assets, see US GAAP Consolidated Financial Statements


           January 24, 2024                                                                                                                                                                   Page 19
                                                                           These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.   Public
Consolidated statements of cash flows € million
Quarter on Quarter
                                                                                                    Q4 2022          Q1 2023          Q2 2023           Q3 2023          Q4 2023
                              Cash and cash equivalents, beginning of period                          3,153            7,268            6,648             6,341            4,976

                          Net cash provided by (used in) operating activities                          5,351               734               385           1,128             3,197
                           Net cash provided by (used in) investing activities                          (364)             (436)             (545)         (1,090)             (617)
                           Net cash provided by (used in) financing activities                          (859)             (916)             (137)         (1,406)             (545)
                                Effect of changes in exchange rates on cash                              (13)               (2)              (10)              3                (6)
                       Net increase (decrease) in cash and cash equivalents                            4,115              (620)             (307)         (1,365)            2,029

                                 Cash and cash equivalents, end of period                              7,268             6,648            6,341            4,976             7,005
                                                  Short-term investments                                 108                 5                5                5                 5
                     Cash and cash equivalents and short-term investments                              7,376             6,653            6,346            4,981             7,010

      Purchases of property, plant and equipment and intangible assets                                  (466)             (539)             (544)            (510)            (602)
                                                      Free cash flow 1                                 4,885               194              (161)             618            2,595


1   Free cash flow, which is a non-GAAP measure, is defined as net cash provided by (used in) operating activities minus purchases of Property, plant and equipment and
    intangible assets, see US GAAP Consolidated Financial Statements


           January 24, 2024                                                                                                                                                                   Page 20
                                                                           These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.   Public
Consolidated balance sheets € million
Year on Year
                                                 Assets                     2019                2020               2021                2022                2023
    Cash & cash equivalents and short-term investments                     4,718               7,352              7,590               7,376               7,010
       Net accounts receivable and finance receivables                     2,773               3,421              4,597               6,680               5,774
                                        Contract assets                      231                 119                165                 132                 240
                                        Inventories, net                   3,809               4,569              5,179               7,200               8,851
                                        Loan receivable                       —                   —                 124                 364                 929
                                           Other assets                    1,673               1,753              1,886               2,383               2,230
                                             Tax assets                      624                 739              1,141               1,706               2,873
                            Equity method investments                        833                 821                893                 924                 920
                                               Goodwill                    4,541               4,629              4,556               4,556               4,589
                                Other intangible assets                    1,105               1,049                952                 842                 742
                         Property, plant and equipment                     1,999               2,470              2,983               3,944               5,493
                                    Right-of-use assets                      324                 345                165                 193                 307
                                           Total assets                   22,630              27,267             30,231              36,300              39,958

                       Liabilities and shareholders' equity
                                            Current liabilities            4,694               6,604             12,298              17,983              16,275
                                         Non-current liabilities           5,344               6,798              7,792               9,506              10,231
                                         Shareholders' equity             12,592              13,865             10,141               8,811              13,452
                  Total liabilities and shareholders' equity              22,630              27,267             30,231              36,300              39,958

     January 24, 2024                                                                                                                                                         Page 21
                                                           These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.   Public
Consolidated balance sheets € million
Quarter on Quarter
                                                 Assets                 Q4 2022             Q1 2023             Q2 2023             Q3 2023             Q4 2023
    Cash & cash equivalents and short-term investments                    7,376               6,653               6,346               4,981               7,010
       Net accounts receivable and finance receivables                    6,680               4,862               5,686               5,682               5,774
                                        Contract assets                     132                 236                 193                 267                 240
                                        Inventories, net                  7,200               7,392               7,734               8,379               8,851
                                        Loan receivable                     364                 364                 364                 921                 929
                                           Other assets                   2,383               2,735               2,912               2,776               2,230
                                             Tax assets                   1,706               1,921               2,275               2,681               2,873
                            Equity method investments                       924                 970               1,040               1,094                 920
                                               Goodwill                   4,556               4,556               4,556               4,583               4,589
                                Other intangible assets                     842                 814                 789                 757                 742
                         Property, plant and equipment                    3,944               4,355               4,728               5,093               5,493
                                    Right-of-use assets                     193                 290                 306                 300                 307
                                           Total assets                  36,300              35,148              36,929              37,514              39,958

                       Liabilities and shareholders' equity
                                            Current liabilities           17,983              16,948              16,755             16,310              16,275
                                         Non-current liabilities           9,506               8,413               9,569              9,209              10,231
                                         Shareholders' equity              8,811               9,787              10,605             11,995              13,452
                  Total liabilities and shareholders' equity              36,300              35,148              36,929             37,514              39,958

     January 24, 2024                                                                                                                                                         Page 22
                                                           These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.   Public
Forward looking statements
This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including
statements with respect to plans, strategies, expected trends, including trends in the semiconductor industry and end markets and business environment trends, including
expected demand, utilization, inventory levels, backlog, bookings, expected recovery in the semiconductor industry and expected timing thereof, assumptions and expectations
with respect to fast shipments, plans to increase capacity, outlook and expected financial results, including expected results for Q1 2024, including net sales, gross margin,
R&D costs, SG&A costs, expected results for full year 2024, including expectations with respect to revenue and gross margin and estimated annualized effective tax rate,
expectations with respect to sales by market segment and EUV, non-EUV and IBM sales and expected drivers thereof, and other full year 2024 expectations, expectations
with respect to revenue growth in 2025 and expected drivers thereof, statements made at our 2022 Investor Day, including revenue and gross margin opportunity for 2025 and
2030, statements with respect to export control policy and regulations and expected impact on us, expectation to return significant amounts of cash to shareholders through
growing dividends and share buybacks, including the amount of shares intended to be repurchased under the program and statements with respect to dividends, statements
with respect to our ESG goals and strategy and other non-historical statements. You can generally identify these statements by the use of words like “may”, “will”, “could”,
“should”, “project”, “believe”, “anticipate”, “expect”, “plan”, “estimate”, “forecast”, “potential”, “intend”, “continue”, “target”, “future”, “progress”, “goal”, “opportunity”, “potential”
and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and
projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future
performance and involve a number of substantial known and unknown risks and uncertainties. These risks and uncertainties include, without limitation, customer demand and
semiconductor equipment industry capacity, worldwide demand for semiconductors and semiconductor manufacturing capacity, utilization and inventory levels, general trends
and consumer confidence in the semiconductor industry, the impact of general economic conditions, including the impact of the current macroeconomic uncertainty on the
semiconductor industry, the impact of inflation, interest rates, geopolitical developments, the impact of pandemics, performance of our systems, the success of technology
advances and the pace of new product development and customer acceptance of and demand for new products, our production capacity and ability to adjust capacity to meet
demand, supply chain capacity, constraints and logistics, timely availability of parts and components, raw materials, critical manufacturing equipment and qualified employees,
and constraints on our ability to produce systems to meet demand, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order
cancellation or push outs and restrictions on shipment of ordered systems under export controls, risks relating to the trade environment, import/export and national security
regulations and orders and their impact on us, including the impact of changes in export regulations and the impact of such regulations on our ability to obtain necessary
licenses and to sell our systems to certain customers, changes in exchange and tax rates, available liquidity and liquidity requirements, our ability to refinance our
indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, the number of shares repurchased under
our share repurchase programs, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation, our ability
to meet ESG goals and execute our ESG strategy, other factors that may impact ASML’s business or financial results, and other risks indicated in the risk factors included in
ASML’s Annual Report on Form 20-F for the year ended December 31, 2022 and other filings with and submissions to the US Securities and Exchange Commission. These
forward-looking statements are made only as of the date of this document. We undertake no obligation to update any forward-looking statements after the date of this report or
to conform such statements to actual results or revised expectations, except as required by law.



         January 24, 2024                                                                                                                                                                       Page 23
                                                                                                                                                                                                Public
Public
